A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Clinical trial NCT00741403 · COMPLETED

Trial details

NCT number: NCT00741403
Sponsor: Cornerstone Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer Lymphoma Solid Tumors Advanced Malignancies

Start date: 2008-08-01
Primary completion: 2016-12-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.